Astellas Pharma International B.V.
Basic information
- Head office
- Tokyo
- Chief executive
- Naoki Okamura
- Capital
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| Avara Norman Pharmaceutical Services, Inc. | ||||||||
| Takeda Pharmaceutical Company, Limited |
Network
History
Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy.![]()
Established in April 2005. Astellas was formed through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical Industry, and a global strategy centered on patients was shaped.![]()
Celebrated its 20th anniversary in April 2025. Astellas was founded in April 2005 through the merger of Yamanouchi Pharmaceutical, established in 1923, and Fujisawa Pharmaceutical Industry, established in 1894. The strengths of Yamanouchi in urology and synthetic technology, and Fujisawa's transplantation, immunology, and fermentation technologies, were integrated to form an optimal partnership that complements each other.![]()
News
There is no news.